Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom".
Saved in:
| Title: | Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom". |
|---|---|
| Authors: | Bretos-Azcona PE; Market Access & HEOR Consulting, Fortrea, London, UK., Wallace M; Market Access & HEOR Consulting, Fortrea, London, UK., Jootun M; Market Access & HEOR Consulting, Fortrea, London, UK., Veljanoska E; Market Access & HEOR Consulting, Fortrea, London, UK., Agirrezabal I; Market Access & HEOR Consulting, Fortrea, London, UK., Szende A; Market Access & HEOR Consulting, Fortrea, London, UK. agota.szende@fortrea.com. |
| Source: | Clinical drug investigation [Clin Drug Investig] 2025 Jul; Vol. 45 (7), pp. 435-438. Date of Electronic Publication: 2025 May 09. |
| Publication Type: | Letter; Comment |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9504817 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1918 (Electronic) Linking ISSN: 11732563 NLM ISO Abbreviation: Clin Drug Investig Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40343676 AccessLevel: 2 PubType: Editorial & Opinion PubTypeId: editorialOpinion PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom". – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Bretos-Azcona+PE%22">Bretos-Azcona PE</searchLink>; Market Access & HEOR Consulting, Fortrea, London, UK.<br /><searchLink fieldCode="AU" term="%22Wallace+M%22">Wallace M</searchLink>; Market Access & HEOR Consulting, Fortrea, London, UK.<br /><searchLink fieldCode="AU" term="%22Jootun+M%22">Jootun M</searchLink>; Market Access & HEOR Consulting, Fortrea, London, UK.<br /><searchLink fieldCode="AU" term="%22Veljanoska+E%22">Veljanoska E</searchLink>; Market Access & HEOR Consulting, Fortrea, London, UK.<br /><searchLink fieldCode="AU" term="%22Agirrezabal+I%22">Agirrezabal I</searchLink>; Market Access & HEOR Consulting, Fortrea, London, UK.<br /><searchLink fieldCode="AU" term="%22Szende+A%22">Szende A</searchLink>; Market Access & HEOR Consulting, Fortrea, London, UK. agota.szende@fortrea.com. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229504817%22">Clinical drug investigation</searchLink> [Clin Drug Investig] 2025 Jul; Vol. 45 (7), pp. 435-438. <i>Date of Electronic Publication: </i>2025 May 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Letter; Comment – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9504817 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1918 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211732563%22">11732563 </searchLink><i>NLM ISO Abbreviation: </i>Clin Drug Investig <i>Subsets: </i>MEDLINE; In Process |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40343676 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40261-025-01443-w Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 435 Titles: – TitleFull: Author's Reply to Perera et al.: A Commentary on "An Early Cost-Utility Model of mRNA-Based Therapies for the Treatment of Methylmalonic and Propionic Acidemia in the United Kingdom". Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Bretos-Azcona PE – PersonEntity: Name: NameFull: Wallace M – PersonEntity: Name: NameFull: Jootun M – PersonEntity: Name: NameFull: Veljanoska E – PersonEntity: Name: NameFull: Agirrezabal I – PersonEntity: Name: NameFull: Szende A IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 07 Text: 2025 Jul Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1179-1918 Numbering: – Type: volume Value: 45 – Type: issue Value: 7 Titles: – TitleFull: Clinical drug investigation Type: main |
| ResultId | 1 |
